Bioversys Sas
Clinical trials sponsored by Bioversys Sas, explained in plain language.
-
New drug cocktail targets superbug pneumonia in hospitals
Disease control Recruiting nowThis study tests a new combination of antibiotics (BV100 plus low-dose polymyxin B) against a standard treatment for a serious lung infection caught in the hospital. The infection is caused by bacteria that are resistant to many current drugs. About 248 adults will take part to s…
Phase: PHASE3 • Sponsor: BioVersys SAS • Aim: Disease control
Last updated May 26, 2026 05:39 UTC
-
Healthy volunteers test drug interaction in early-stage trial
Knowledge-focused Recruiting nowThis early-stage study looks at whether a new drug called BV100 changes how the body handles another drug, polymyxin B. It involves 16 healthy adults who will receive both drugs in a set order. The goal is to measure drug levels and check for side effects, not to treat any diseas…
Phase: PHASE1 • Sponsor: BioVersys SAS • Aim: Knowledge-focused
Last updated May 26, 2026 05:52 UTC